Hydrogen Future (HFCO) Inactive 10-Q2011 Q4 Quarterly report

Filed: 21 Feb 12, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	8th grade Avg

New words: agreement, assigned, ASU, attributable, authoritative, book, calculated, calculation, case, certificate, clarification, Collateral, condensed, consecutive, contrary, correlation, corroborated, creation, decided, deficiency, dispute, enterprise, evidence, exceed, exit, exposure, fall, federally, Finally, fully, hierarchical, institution, language, listed, lived, maximum, memorialized, monthly, multiplied, newly, notice, ownership, partial, PEO, percent, permitted, PFO, preferred, premium, principle, proper, prospectively, quality, quantity, reclassification, recovered, redemption, refundable, registration, relationship, renewed, rental, retrospectively, seventy, unadjusted, vi, vii, wording

Removed: adequate, commence, committee, correct, COSO, criteria, detect, establishing, evaluate, executed, fairly, hire, incur, inherent, insufficient, insure, Integrated, Lachine, lack, maintaining, performing, person, personnel, prevent, realized, require, requisite, reserved, responsible, segregation, Sponsoring, submitted, Treadway, written

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

HFCO similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF

THE SARBANES-OXLEY ACT OF 2002

In connection with this Quarterly Report of A5 Laboratories Inc. (the “Company”), on Form 10-Q for the quarter ended December 31, 2011, as filed with the U.S. Securities and Exchange Commission on the date hereof, I, Richard Azani, Principal Financial Officer of the Company, certify to the best of my knowledge, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:

(1)

Such Quarterly Report on Form 10-Q for the quarter ended December 31, 2011, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in such Quarterly Report on Form 10-Q for the quarter ended December 31, 2011, fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: February 21, 2012	By:	/s/ Richard Azani
		Richard Azani
		Principal Financial Officer A5 Laboratories Inc.